AlphAIAlphAI — Financial news for AI agents
investing.comSEP 162 min read$CNO

CNO Financial Group chief actuary sells $487,321 in shares

CNO Financial Group's Chief Actuary, Jeremy D. Williams, sold 8,782 shares ($487,321) and acquired 7,660 shares ($168,674) via options. CNO reported Q2 2026 earnings of $1.26 per share, beating estimates, and raised its full-year profit outlook. Texas Capital Securities initiated coverage with a Buy rating and $70 target. CNO trades near its 52-week high.

Original reporting
investing.com
Published Sep 16, 2026, 11:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 3:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CNO
Neutral
medium confidence
Mentioned
$CNO
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The earnings beat reinforces growth narrative, while the insider sale introduces a modest bearish nuance.

02

Market read

Combines fresh earnings strength with a modest insider divestiture, yielding mixed short‑term signals.

03

What to watch

Recent strong Q2 earnings and upgraded coverage could offset negative perception.

Relevance 4/10Novelty 4/10Timing: same‑day insider sale

Background

CNO reported Q2 2026 earnings beat and raised full‑year outlook; coverage initiated with a $70 target.

Company-level read

Ticker impact

$CNONeutralMedium confidence
Context

Chief actuary Jeremy D. Williams sold 8,782 CNO shares for $487,321 under a Rule 10b5‑1 plan on Sep 15‑16, 2026.

Expected impact

modest short‑term dip

Evidence & confidence

Sale size is modest relative to float; executed via pre‑arranged plan, reducing strong signal strength.

Market effects

Sector

Minimal impact on insurance sector; insider activity is routine.

Regional

No broader regional effect.

Global

Limited to CNO investors.

Counterpoint

What could challenge this read

Insider sale could be unrelated to confidence; may reflect personal liquidity needs.

Key entities

  • Company
    CNO Financial Group

    Insurance holding company (NASDAQ:CNO).

  • Executive
    Jeremy D. Williams

    Chief actuary who executed the insider sale.

Read at source← All news

Related articles

SEP 12
$CNOMed

CNO Financial Group (CNO) Beats In Q2 But Is The Rally Already Priced In

CNO Financial Group (CNO) reported Q2 revenue beating expectations, with operating earnings per share up 45% and 16 consecutive quarters of sales growth. The stock is up 30.19% year-to-date and 42.14% over one year. However, it is slightly overvalued according to a narrative fair value of $53.50. Growth is driven by annuity and life/health policy sales, digital channels, and an aging U.S. population. Risks include low long-term interest rates and rising long-term care claims.

simplywall.st2 min
AUG 17
$CNOMed

California Nanotechnologies Posts 28% Revenue Growth in Q1 FY2027 as Nuclear Pivot Takes Hold

California Nanotechnologies (TSXV:CNO) reported Q1 FY2027 revenue of $917,854, up 28% from $716,553 a year earlier, for the quarter ended May 31, 2026. Adjusted EBITDA loss narrowed to $129,031 from $152,707, while net loss was $449,598. The company attributes growth to customer diversification and a nuclear supply-chain pivot tied to initial SMR component purchase orders.

kalkine.ca6 min
AUG 14
$CNOHighAI 9/10

CNO Financial (CNO) Q2 2026 Earnings Call Transcript

CNO Financial Group (NYSE:CNO) reported Q2 2026 operating EPS of $1.26, up 45% year over year, and net operating income of $119.5 million. Total new annualized premiums rose 7% to a record. Full-year EPS guidance was raised to $4.60 to $4.80. The company also repurchased $60 million of shares.

aol.com6 min
JUL 31
$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

insurancebusinessmag.com5 min
JUL 30
$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

financialcontent.com4 min
JUL 30
$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Second Quarter 2026 Results Carmel, Ind., July 30, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its second quarter 2026 financial results: • Strong execution and momentum continues; Raising 2026 operating earni

SEC EDGAR 8-K6 min